VAX-24 Phase 1/2 Adult Proof-of-Concept Data Published in The Lancet Infectious…
-- In the Study, VAX-24 Demonstrated a Safety and Tolerability Profile Similar to Prevnar 20® (PCV20) at all Doses Studied -- -- All 24 Serotypes of VAX-24 at Conventional 2.2 mcg PCV Dose…